‘Tepid’ response to CRISPR embryo editing could lead to regulations, Gottlieb says

The scientific community’s response to reports of human germline editing by Chinese researcher Jiankui He has been too little and too late, and governments may respond with heavy handed regulations, FDA Commissioner Scott Gottlieb told BioCentury. NIH Director Francis Collins released a statement calling

Read the full 448 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE